Small Peptide-Based Nanodelivery Systems for Cancer Therapy and Diagnosis

Area of Science:

• Biomedical Engineering
• Materials Science
• Oncology

Background:

• Cancer remains a significant global health concern, necessitating advanced therapeutic strategies.
• Peptide-based nanomaterials present superior biocompatibility, biochemical, and biophysical properties compared to synthetic alternatives.
• Customizable nano-biomaterials with tunable topology, size, and surface characteristics show promise in biomedical applications.

Purpose of the Study:

• To review the diverse roles of peptide-based nanostructures in cancer theranostics.
• To explore the self-assembly mechanisms of peptides into hierarchical nanostructures.
• To comprehensively analyze the applications of peptide-based nanostructures in cancer therapy and diagnosis.

Main Methods:

• Literature review of peptide-based nanostructures in cancer theranostics.
• Exploration of peptide self-assembly mechanisms.
• Analysis of applications in cancer therapy and diagnosis.

Main Results:

• Peptide-based drug delivery systems demonstrate enhanced bio- and cytocompatibility.
• Peptides conjugated with chemotherapeutics improve drug targetability at cancer sites, reducing nonspecific effects.
• Various peptide-based nanostructures show significant potential in cancer diagnosis and therapy.

Conclusions:

• Peptide-based nanostructures are pivotal in advancing cancer theranostics.
• Their tunable properties and enhanced targeting capabilities offer a revolutionary approach to cancer treatment and diagnosis.
• Further development of these nano-biomaterials holds immense promise for improving patient outcomes.